We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$79.7B
AUM Growth
+$3.42B
(+4.5%)
Cap. Flow
-$854M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
14.29%
Holding
1,817
New
122
Increased
851
Reduced
711
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$281M |
| 2 |
Comcast
CMCSA
|
+$235M |
| 3 |
Apple
AAPL
|
+$172M |
| 4 |
MetLife
MET
|
+$151M |
| 5 |
Mid-America Apartment Communities
MAA
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$399M |
| 2 |
UBS Group
UBS
|
+$393M |
| 3 |
Televisa
TV
|
+$305M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$278M |
| 5 |
New Oriental
EDU
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.42% |
| 2 | Financials | 13.04% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 11.9% |
| 5 | Technology | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Vertex Pharmaceuticals
VRTX
$121B
| $136M | 0.17% |
1,562,258
+219,382
| +16% | +$20.7M |
|
|
MEG
152
DELISTED
Media General, Inc
MEG
| $136M | 0.17% |
7,366,080
| – | – |
|
153
Eastman Chemical
EMN
$7.8B
| $136M | 0.17% |
2,002,196
+278,738
| +16% | +$18.7M |
|
154
Fomento Económico Mexicano
FMX
$43.3B
| $135M | 0.17% |
+1,462,419
| New | +$135M |
|
155
Eaton
ETN
$157B
| $133M | 0.17% |
2,028,282
+133,230
| +7% | +$8.62M |
|
156
Coca-Cola
KO
$354B
| $133M | 0.17% |
3,149,247
+152,394
| +5% | +$6.68M |
|
|
SHLX
157
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $132M | 0.17% |
4,123,134
-622,401
| -13% | -$19.6M |
|
158
Vulcan Materials
VMC
$36.3B
| $131M | 0.17% |
1,155,879
-971,659
| -46% | -$115M |
|
159
Deere & Co
DE
$170B
| $131M | 0.16% |
1,537,887
+497,608
| +48% | +$40.7M |
|
|
WBA
160
DELISTED
Walgreens Boots Alliance
WBA
| $131M | 0.16% |
1,627,018
+214,820
| +15% | +$17.5M |
|
|
CERN
161
DELISTED
Cerner Corp
CERN
| $131M | 0.16% |
2,117,506
-236,103
| -10% | -$14.9M |
|
162
Honeywell
HON
$77.1B
| $130M | 0.16% |
1,241,797
-127,687
| -9% | -$13.3M |
|
|
CONE
163
DELISTED
CyrusOne Inc Common Stock
CONE
| $129M | 0.16% |
2,719,382
+375,730
| +16% | +$19.4M |
|
|
NSH
164
DELISTED
NuStar GP Holdings LLC
NSH
| $126M | 0.16% |
4,945,117
-12,202
| -0.2% | -$298K |
|
165
PPG Industries
PPG
$25.9B
| $125M | 0.16% |
1,209,561
+142,402
| +13% | +$14.9M |
|
166
Newmont
NEM
$98.2B
| $125M | 0.16% |
3,170,172
-969,824
| -23% | -$40.2M |
|
167
Intercontinental Exchange
ICE
$82.4B
| $124M | 0.16% |
2,308,655
+492,030
| +27% | +$26.9M |
|
168
Blackrock
BLK
$164B
| $123M | 0.15% |
339,599
-109,728
| -24% | -$39.9M |
|
169
eBay
EBAY
$48.6B
| $122M | 0.15% |
3,705,811
+12,091
| +0.3% | +$365K |
|
170
Stryker
SYK
$127B
| $120M | 0.15% |
1,029,929
+747,665
| +265% | +$87.1M |
|
171
Prologis
PLD
$138B
| $119M | 0.15% |
2,224,747
+1,060,397
| +91% | +$56M |
|
172
Equinix
EQIX
$107B
| $119M | 0.15% |
329,002
+44,222
| +16% | +$16.4M |
|
173
A.O. Smith
AOS
$8.38B
| $117M | 0.15% |
2,378,754
-774,676
| -25% | -$36.2M |
|
|
COHR
174
DELISTED
Coherent Inc
COHR
| $116M | 0.15% |
1,048,912
+9,194
| +0.9% | +$953K |
|
175
Allstate
ALL
$66.9B
| $115M | 0.14% |
1,659,351
+297,625
| +22% | +$20.5M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q3 2016 Portfolio in Review
As of Q3 2016, OppenheimerFunds held 1,817 positions worth $79.7B, up 4.5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q3 2016 filing shows 122 new, 851 increased, 711 reduced and 96 closed positions. Its largest new stake was Fomento Económico Mexicano: 1,462,419 shares worth $135M. The largest sale was Bristol-Myers Squibb, an estimated $399M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q3 2016 buy was Fomento Económico Mexicano: 1,462,419 shares worth $135M.
- OppenheimerFunds added most to Johnson Controls International in Q3 2016, an estimated $281M increase.
- OppenheimerFunds's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $399M.
- OppenheimerFunds fully exited UBS Group in Q3 2016, selling an estimated $393M.
- OppenheimerFunds's ten largest holdings make up 14% of its $79.7B portfolio in Q3 2016.
- OppenheimerFunds opened 122 new positions and closed 96 in Q3 2016.
- OppenheimerFunds's portfolio value rose 4.5% quarter-over-quarter to $79.7B.
Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.